cadence pharmaceuticals inc
(CADX:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)

Executive Profile*

Background*

Mr. Theodore R. Schroeder, Ted Co-Founded Cadence Pharmaceuticals Inc., in May 2004 and has been its President and Chief Executive Officer since May 2004. Prior to founding Cadence, Mr. Schroeder served as the Senior Vice President of North American Sales and Marketing for Elan with responsibility for all pharmaceutical commercial operations, including the primary care, neurology, and hospital franchises. These products had 2002 U.S. net sales of over $900 million, and ... his organization was comprised of over 900 individuals. Previously, he served as General Manager of the Elan Hospital Products Business Unit, which included three injectable anti-infectives: Maxipime, Azactam, and Abelcet. Mr. Schroeder held the same position at Dura Pharmaceuticals. He held a number of hospital-related sales and marketing positions with Bristol-Myers Squibb with increasing levels of responsibility. He has been an Independent Director of Trius Therapeutics, Inc. since December 2009. Mr. Schroeder has been a Director of Cadence Pharmaceuticals Inc., since May 2004. He serves as a Director of Incline Therapeutics, Inc. Mr. Schroeder holds a B.S. in Management from Rutgers University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CADX:US	$6.93 USD	+0.23

COMPETITOR COMPENSATION